Browsing: trial

A breast cancer survivor says she no longer lives “with the same fear” after a clinical trial enabled her to…

In a community-based trial in rural China, an intensive blood-pressure lowering intervention reduced the incidence of dementia compared with usual…

A TAVI-first strategy was noninferior to a PCI-first strategy after one years’ follow-up, according to results presented in a Hot…

Jury deliberations are expected to resume in the trial of Lindsay Clancy. The defense argues that Clancy suffered from postpartum…

Monotherapy using prasugrel failed to show noninferiority compared with potent antiplatelet therapy plus aspirin at the time of primary percutaneous…

Antiplatelet monotherapy reduced bleeding but dual therapy provided greater cardiovascular event protection in patients at high ischemic risk who had…

Functional coronary angiography significantly reduced cardiovascular events and improved safety compared with conventional angiography in patients with ST-segment elevation myocardial…

Through weeks of testimony, defense attorney Kevin Reddington tried to convince those jurors that, in the months before the killings,…

Prasugrel reduced major cardiovascular events to the same extent as ticagrelor but with lower major bleeding after coronary stenting in…

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic…